Successful Ceram is in acquisition mode


The Ceram Group is on the hunt for acquisitions after posting a jump in annual net profits, says


Ceram, which specialises in materials analysis and testing, said net profits increased 79% to £717,000 in the year 30 April 2012. Turnover also rose to £12.7 million, an increase of 8% on the previous year.


The Ceram Group has now instructed Grant Thornton to find suitable acquisitions and it looks to the next stage of its growth.


Tony Kinsella, Chief Executive said, "We’re looking to acquire complementary testing businesses as well as businesses that can add to our materials expertise in technologies such as polymers."


Read the full story here


Readers of Med-Tech Innovation will have noticed that experts at Ceram are regular contributors to the magazine providing insights into advances in hydroxyapatites, the characterisation of cardiovascular stents, cleaning process validation and much more.


All the published articles can be found on our website in Article Archive.

Related News

Will More Policy Mean Less Technology?


This industry fear is to be discussed at the 2011 Health Technology Summit on 14 April 2011 in Washington, DC, USA. One year after healthcare reform in the US, the event will address what affect this is having on med-tech innovation. ... read more >

Diagnostics company Biocartis is fully financed


Biocartis has raised euro 71 million in series C financing from J&J, the Wellcome Trust and other investors. ... read more >

Ceram launches Regulatory Approval package


The materials technology company has launched a Regulatory Approval Service designed to help hydroxyapatite users and manufacturers gain FDA approval.... read more >

Copyright © 2014 Med-Tech Innovation
Submit Editorial | Media Kit | Privacy Policy | Terms of Service | Site map